Research shows the p-tau217 blood test can indicate very high risk of Alzheimer's disease before symptoms begin, offering ...

GLP-1 drugs, which include Ozempic and Wegovy, have become one of the most closely watched experimental approaches for ...

Major Alzheimer’s breakthroughs in 2025 include new FDA-approved blood tests, at-home treatments, and lifestyle research showing cognitive benefits for older adults.

A new study reveals that obesity accelerated Alzheimer's blood biomarkers by 95% over five years, highlighting a strong ...

UD's DementiaBank outshines global competitors, driving machine-learning advances in early dementia prediction ...

High levels of calcium are toxic to cells and contribute to loss of neurons in Alzheimer’s disease. Researchers found that a ...

Researchers are developing a greater understanding of Parkinson’s disease, the fastest growing neurodegenerative disease ...

Brittany Butts understands that for many families, Alzheimer's comes as a double burden. As a teenager, she watched not only ...

Researchers have conducted the first study evaluating the impact of obesity on Alzheimer's disease blood biomarkers (BBMs).

Alzheimer’s disease accounts for most of the cases of dementia, a condition characterized by progressive or persistent loss ...

A new statewide spatial analysis of Alzheimer's disease and related dementias (ADRD) has uncovered significant disparities in ...

A study of aging mice showed that voluntary exercise over 30 days increased striatal dopamine release and improved motor ...